Evidence map›Paper›PMID 42338600›Full record

ArticleFrontiers in immunology2026

IFNγ-producing iNKTs restrict a live-attenuated chlamydia oral vaccine in the large intestine.

Ahmed Mohamed Abdelsalam, Yi Wu, Mitchell Kronenberg, Huizhou Fan, Guangming Zhong

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Ahmed Mohamed AbdelsalamDepartment of Microbiology, Immunology and Molecular Genetics, University of Texas Health Science Center at San Antonio, San Antonio, TX, United States.
Yi WuDepartment of Microbiology, Immunology and Molecular Genetics, University of Texas Health Science Center at San Antonio, San Antonio, TX, United States.
Mitchell KronenbergLa Jolla Institute for Immunology, La Jolla, CA, United States.
Huizhou FanDepartment of Pharmacology, Robert Wood Johnson Medical School, Piscataway, NJ, United States.
Guangming ZhongDepartment of Microbiology, Immunology and Molecular Genetics, University of Texas Health Science Center at San Antonio, San Antonio, TX, United States.

Funding

An oral vaccine against Chlamydia trachomatisU01AI182210 · NIAID · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI GUANGMING ZHONG · 2024 to 2026
$6.5M
NIAID NIH HHS U01 AI182210
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Bacterial VaccinesChlamydia InfectionsChlamydia muridarumInterferon-gammaIntestine, LargeAdministration, OralAnimalsFemaleMiceMice, Inbred C57BLMice, KnockoutVaccines, AttenuatedBacterial VaccinesInterferon-gammaVaccines, Attenuatedchlamydia oral vaccineIFNγiNKTsintrOvlarge intestine

Identifiers

PMID42338600
PMCPMC13284539

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.